French trial aims to slash tuberculosis treatment time in half
NCT ID NCT07486024
Summary
This study is testing a new, much shorter 6-month drug combination for adults with multidrug-resistant tuberculosis (MDR-TB) in France. It will compare the new regimen's success rate to the results from patients who received older, much longer treatments (often 18+ months). The goal is to see if the shorter treatment works just as well, which could make therapy easier and faster for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pitié-Salpêtrière Hospital - infectious and tropical diseases
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.